Cargando…
Efficacy of Olfactory and Pareidolia Tests Compared With That of Indicative Biomarkers in Diagnosis of Dementia With Lewy Bodies
Purpose: Although olfactory decline and visual hallucinations are useful in distinguishing dementia with Lewy bodies (DLB) from Alzheimer's disease (AD) in a clinical setting, neither is easy to evaluate objectively. The pareidolia test is used to assess susceptibility to visual hallucinations,...
Autores principales: | Inagawa, Yuta, Kanetaka, Hidekazu, Tsugawa, Akito, Sakurai, Shu, Serisawa, Shuntaro, Shimizu, Soichiro, Sakurai, Hirofumi, Hanyu, Haruo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517047/ https://www.ncbi.nlm.nih.gov/pubmed/33041991 http://dx.doi.org/10.3389/fneur.2020.540291 |
Ejemplares similares
-
Differentiating Mild Cognitive Impairment, Alzheimer's Disease, and Dementia With Lewy Bodies Using Cingulate Island Sign on Perfusion IMP-SPECT
por: Kanetaka, Hidekazu, et al.
Publicado: (2020) -
Association between clinical symptoms and post‐mortem neuropathology in dementia with Lewy bodies
por: Kaneko, Yoshitsugu, et al.
Publicado: (2020) -
Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer’s disease
por: Shimizu, Soichiro, et al.
Publicado: (2015) -
Association of regional white matter hyperintensity volumes with cognitive dysfunction and vascular risk factors in patients with amnestic mild cognitive impairment
por: Hirao, Kentaro, et al.
Publicado: (2021) -
Association of White Matter Hyperintensity Progression with Cognitive Decline in Patients with Amnestic Mild Cognitive Impairment
por: Hirao, Kentaro, et al.
Publicado: (2021)